The tweet was deleted by the author.
But we saved everything 🙂.
Twist Bioscience announced that target capture-based long-read sequencing was used to unravel missing variants in autosomal recessive disorders.
Twist Bioscience thanked the athleta for choosing the company to support this work. Further details were shared via a linked post.
View post on X Loading...
TWST is currently trading at $90.40, positioned below the MA-20 at $92.37 but above the MA-50 at $81.84 and well above the MA-200 at $51.97. This setup indicates short-term resistance from sellers, a supportive medium-term uptrend, and robust long-term bullish structure. The Ichimoku Kijun at $93.48 sits above price and acts as immediate resistance. Near-term support is found at the MA-50 ($81.84), with key support at the MA-100 ($67.02). Resistance is defined near MA-20 ($92.37), with the Ichimoku Kijun ($93.48) as key resistance.
Momentum signals from MACD on D1 are bullish, but ADX on D1 points to waning trend strength and a short-term sell. Multiple oscillators (RSI, Stoch RSI, CCI) all flag oversold conditions, suggesting the recent selloff may be stretched, while BBP readings confirm sellers continue to dominate intraday flows. The Awesome Oscillator currently supports the bearish direction. In today’s session, the stock jumped 5.77% to $90.40, reflecting strong intraday buying. For the week, TWST is trading at $90.40, modestly higher from the previous week’s close at $90.27, a gain of 0.34%. The price is clustered in the upper part of the weekly range, with weekly volatility at 15.11%. The tone across the week favors consolidation after a sharp reversal from the lows, although short-term indicators remain conflicted.
Looking ahead, the expected price range for TWST over the next week is $82.00 to $98.00, which remains well above the 52-week low of $23.30 but below resistance at the 52-week high of $105.41. Based on weekly signals—RSI-W1, ADX-W1, MACD-W1, and MA-50-W1—all giving a buy forecast, there is a very high probability (more than 80%) of price increase, with the probability of decline rated as very low. The baseline scenario sees price consolidating between near-term support at $82.00 and resistance at $98.00. A bullish breakout above $98.00 could open the path toward a retest of the yearly highs near $105.00, while a failure to hold $82.00 risks a pullback toward the MA-100 at $67.00. The overall setup favors a bullish bias, anchored by strong long-term trends and improving momentum on the weekly horizon.
Earlier, analysts noted that Twist Bioscience was maintaining a bullish long-term outlook despite short-term technical pressures and heightened volatility. This article adds a new dimension by evaluating the most recent market catalysts and highlights the importance of monitoring shifts in buyer activity as a signal for a sustained move in either direction.